Inventor

CLARK ABBOT F

US57 patents

⚠️ This page may combine multiple inventors who share the name “CLARK ABBOT F”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CLARK ABBOT F

ALCON LAB INC

Angiostatic steroids

Angiostatic agents and methods and compositions for controlling ocular hypertension

Prevention and treatment of ocular neovascularization using angiostatic steroids

Prevention and treatment of ocular neovascularization by treatment with angiostatic steroids

Estrogen metabolites for lowering intraocular pressure

Angiostatic steroids and methods and compositions for controlling ocular hypertension

Use of tetrahydrocortexolone to prevent elevations in intraocular pressure caused by corticosteroids

Methods for controlling ocular hypertension with angiostatic steroids

Combination therapy for lowering and controlling intraocular pressure

Treatment of GLC1A glaucoma with glucocorticoid antagonists

Ophthalmic composition

Treatment of glaucoma and ocular hypertension

A-seco steroids effective at treating ophthalmic pathological neovascularization and controlling intraocular pressure

Angiostatic steroids and methods and compositions for controlling ocular hypertension

Substituted hydrindanes for the treatment of angiogenesis-dependent diseases

Substituted hydrindanes for the treatment of angiogenesis-dependent diseases

Treatment of GLC1A glaucoma with non-steroidal glucocorticoid antagonists

Treatment of ocular hypotony

TGFα for the treatment of ocular hypertension and glaucoma

Hepatocyte growth factor to treat glaucoma

ALCON INC

RNAi-mediated inhibition of frizzled related protein-1 for treatment of glaucoma

RNAi-mediated inhibition of ocular targets

Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma

Agents which regulate, inhibit, or modulate the activity and/or expression of connective tissue growth factor (CTGF) as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies

Method for treating glaucoma comprising administering to a patient in need thereof a composition comprising an antibody against gremlin

Use of serum amyloid A gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents

Bone morphogenic proteins (BMP), BMP receptors and BMP binding proteins and their use in the diagnosis and treatment of glaucoma

Use of serum amyloid a gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents

Use of non-feminizing estrogens as retinoprotective agents for the treatment of glaucoma

Use of TIMP-3 inducers of TIMP-3 expression, and TIMP-3 mimetics to treat ocular neovascularization

ARROWHEAD RES CORP

Transferrin/transferrin receptor-mediated siRNA delivery

RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions

Transferrin/transferrin receptor-mediated siRNA delivery

RNAI-mediated inhibition of frizzled related protein-1 for treatment of glaucoma

RNAi-related inhibition of TNF-alpha signaling pathway for treatment of ocular angiogenesis

CHATTERTON JON E

Transferrin/transferrin receptor-mediated siRNA delivery

RNAi-mediated inhibition of Rho kinase for treatment of ocular disorders

RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions

ALCON MFG LTD

Use of angiostatic steroids in photodynamic therapy

Use of AP-1 activators to treat glaucoma and ocular hypertension

ALCON RES LTD

Transferrin/transferrin receptor-mediated siRNA delivery

Superoxide dismutase-2 expression for glaucoma diagnosis

CLARK ABBOT F

RNAi-mediated inhibition of frizzled related protein-1 for treatment of glaucoma

Use of tetrahydrocortisol to prevent elevations in intraocular pressure caused by corticosteroids

ARROWHEAD PHARMACEUTICALS INC

Transferrin/transferrin receptor-mediated siRNA delivery

RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions

ALCON UNIVERSAL LTD

Sub-tenon drug delivery

(unassigned)

Use of PARP inhibitors in the treatment of glaucoma

UNIV IOWA RES FOUND

Diagnostics and therapeutics for glaucoma

UNIV NORTH TEXAS

Methods for diagnosing glaucoma and discovering anti-glaucoma drugs